Biotech Stocks Rally Hantavirus: Is the Move Overdone?
A limited hantavirus outbreak has sent waves through biotech stocks, mirroring post-pandemic behavior. This article b...
Identify essential line items for unexpected bills and set aside funds to smooth out financial shocks. A clear plan reduces anxiety and keeps spending in check.
15,931 articlesA limited hantavirus outbreak has sent waves through biotech stocks, mirroring post-pandemic behavior. This article b...
A fund’s big move out of a top-performing pharma stock can puzzle investors. Here’s a clear, practical look at what k...
The Senate Banking Committee advances toward Thursday's CLARITY Act markup amid a surge of amendments and lobbying, s...
The market is hovering around record levels, but does that mean you should sit on the sidelines? Not necessarily. Thi...
A routine ethics filing has become a focal point for investors and policymakers. This deep dive explains what the qua...
A policy debate on how the Social Security Administration recovers overpayments could reshape retirees’ income. If er...
NextEra Energy announces a $67 billion all-stock deal to buy Dominion Energy, a move that could kick off a broader wa...
The S&P 500 just completed straight week, marking a notable stretch of gains. This article breaks down what it could ...
A major fund boosted its Nomad Foods stake as the stock faced a tough year. Explore what this move means for risk, va...
California lawmakers move to tighten a five-year-old starter-home law, with SB 1116 clearing the Senate 37-0 and head...
Stocks closed higher for an eighth straight week as earnings buoy sentiment, even as a key consumer confidence gauge ...
When a flagship endowment changes its crypto holdings, it offers a rare peek into risk management. This guide breaks ...